EVALUATION OF STRUCTURE AND CAUSES FOR SWITCHING BDMARDS AND JAK INHIBITORS IN PATIENTS WITH RHEUMATOID ARTHRITIS

被引：0
|
作者：
Bobkova, A. O. [1 ]
Potapova, A. S. [1 ]
Sholkina, P. A. [1 ]
Karateev, A. E. [1 ]
Polishchuk, E. Y. U. [1 ]
Lila, A. M. [1 ]
机构：
[1] VA Nasonova Res Inst Rheumatol, Moscow, Russia
来源：
AGING CLINICAL AND EXPERIMENTAL RESEARCH | 2024年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
P219
引用
收藏
页码：S149 / S149
页数：1
相关论文
共 50 条
  • [21] Drug Survival of JAK Inhibitors and Biologic DMARDs in Rheumatoid Arthritis Patients
    Chow, Jocelyn
    Sraka, Gabrielle
    Chau, Kristie
    Soucy, Elaine
    Chow, Andrew
    JOURNAL OF RHEUMATOLOGY, 2022, 49 (07) : 797 - 798
  • [22] Selective JAK inhibitors in development for rheumatoid arthritis
    Norman, Peter
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2014, 23 (08) : 1067 - 1077
  • [23] Chemical JAK inhibitors for the treatment of rheumatoid arthritis
    Nakayamada, Shingo
    Kubo, Satoshi
    Iwata, Shigeru
    Tanaka, Yoshiya
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (16) : 2215 - 2225
  • [24] Janus Kinase (JAK) Inhibitors in Rheumatoid Arthritis
    Yamaoka, Kunihiro
    Tanaka, Yoshiya
    CURRENT RHEUMATOLOGY REVIEWS, 2011, 7 (04) : 306 - 312
  • [25] Risk of Infections Between JAK Inhibitors and TNF Inhibitors Among Patients with Rheumatoid Arthritis
    Choi, Se Rim
    Shin, Anna
    Ha, You-Jung
    Lee, Yun Jong
    Lee, Eun Bong
    Kang, Eun Ha
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 589 - 590
  • [26] RISK OF INFECTIONS BETWEEN JAK INHIBITORS AND TNF INHIBITORS AMONG PATIENTS WITH RHEUMATOID ARTHRITIS
    Choi, S. R.
    Shin, A.
    Ha, Y. J.
    Lee, Y. J.
    Lee, E. B.
    Kang, E. H.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 716 - 716
  • [27] ASSESSMENT OF THE RESPONSE TO THERAPY WITH CSDMARDS AND BDMARDS IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Boyadzhieva, Vladimira
    Stoilov, Nikolay
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1573 - 1573
  • [28] Incidence of major adverse cardiovascular events in patients with rheumatoid arthritis treated with JAK-inhibitors compared to bDMARDs: data from an international collaboration of registries (the "JAK-pot" study)
    Aymon, R.
    Mongin, D.
    Bergstra, S. A.
    Choquette, D.
    Codreanu, C.
    Cordtz, R. L.
    De Cock, D.
    Dreyer, L.
    Elkayam, O.
    Huschek, D.
    Hyrich, K. L.
    Iannone, F.
    Inanc, N.
    Kearsley-Fleet, L.
    Kvien, T. K.
    Leeb, B. F.
    Lukina, G.
    Nordstrom, D.
    Onen, F.
    Pavelka, K.
    Pombo-Suarez, M.
    Provan, S.
    Rodrigues, A. M.
    Rotar, Z.
    Strangfeld, A.
    Verschueren, P.
    Zavada, J.
    Courvoisier, D.
    Finckh, A.
    Lauper, K.
    SWISS MEDICAL WEEKLY, 2023, 153 : 2S - 2S
  • [29] INCIDENCE OF MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH JAK-INHIBITORS COMPARED TO BDMARDS: DATA FROM AN INTERNATIONAL COLLABORATION OF REGISTRIES (THE "JAK-POT" STUDY)
    Aymon, R.
    Mongin, D.
    Bergstra, S. A.
    Choquette, D.
    Codreanu, C.
    Cordtz, R. L.
    Diederik, D. C.
    Dreyer, L.
    Elkayam, O.
    Huschek, D.
    Hyrich, K.
    Iannone, F.
    Inanc, N.
    Kearsley-Fleet, L.
    Kvien, T. K.
    Leeb, B.
    Lukina, G.
    Nordstrom, D.
    Onen, F.
    Pavelka, K.
    Pombo-Suarez, M.
    Provan, S. Aarrestad
    Rodrigues, A. M.
    Rotar, Z.
    Strangfeld, A.
    Verschueren, P.
    Zavada, J.
    Courvoisier, D.
    Finckh, A.
    Lauper, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 143 - 145
  • [30] SAFETY OF JAK INHIBITORS IN PATIENTS WITH RHEUMATOID ARTHRITIS IN CONDITIONS OF DAILY CLINICAL PRACTICE
    Cid Boza, Natalia
    Velloso Feijoo, M. L.
    Nahia, Plaza
    Luis Marenco, Jose
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1681 - 1682
12345